Partner Headlines - LLY

  1. 5 'Key Pipeline Catalysts' To Watch At Eli Lilly

    Benzinga
  2. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD
  3. IPO Alert: Biotech Investors Should Watch Advanced Accelerator's ...

    Benzinga
  4. UBS: Eli Lilly's 'Outlook Continuing To Improve'

    Benzinga
  5. Eli Lilly CEO Explains The Reasons Behind Not Changing 2015 Guidance ...

    Benzinga
  6. Viekira Pak View Falls Short

    IBD
  7. AbbVie Beats, But Stock Falls; Lilly Cuts Guidance

    IBD
  8. UPDATE: Eli Lilly Posts Upbeat Q4 Profit, Sales Decline

    Benzinga
  9. Earnings Scheduled For January 30, 2015

    Benzinga
  10. 10 Must Watch Stocks for Today

    Benzinga
  11. Box Ready To Unwrap IPO In Hot Online Storage Field

    IBD
  12. Feeling Good With This Med Company

    GuruFocus
  13. Eli Lilly

    IBD
  14. Here Is Goldman Sachs' Potential Pair Trade For 2 Drug Giants

    Benzinga
  15. 10 Biotech Stories You Might've Missed This Week

    Benzinga
  16. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  17. Exclusive: JPMorgan Chase CEO Jamie Dimon Talks Cancer Recovery, ...

    FoxBusiness
  18. Eil Lilly CEO Talks New Product Launches, Pricing Pressure From ...

    Benzinga
  19. FDA Issues Import Block On Eli Lilly's Cialis

    Benzinga
  20. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  21. Deutsche Bank, Stifel Differ On Outlook For Eli Lilly

    Benzinga
  22. Benzinga's Top Upgrades

    Benzinga
  23. Jefferies Upgrades Eli Lilly To Buy

    Benzinga
  24. UPDATE: Deutsche Bank Downgrades Eli Lilly On Positive Outlook, ...

    Benzinga
  25. Eli Lilly

    IBD
  26. Alkermes Hits High On Schizophrenia Drug Results

    IBD
  27. Eli Lilly Moves Higher Following FY 2014 & 2015 Outlook

    Benzinga
  28. Benzinga's Top #PreMarket Losers

    Benzinga
  29. Fast Money Halftime Report Final Trade From January 6

    Benzinga
  30. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga
  31. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  32. 7 Stocks You Should Be Watching Today

    Benzinga
  33. Eli Lilly

    IBD
  34. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  35. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD
  36. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  37. Zosano Pharma and Eli Lilly and Company Enter Into Exclusive ...

    Benzinga
  38. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD
  39. Screening Pharma Stocks Amid Turnaround

    YCharts
  40. Sarah Ketterer Dives in when Others Pull Out

    GuruFocus
  41. Credit Suisse Raises Eli Lilly Price Target

    Benzinga
  42. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  43. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  44. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  45. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  46. Earnings Scheduled For October 23, 2014

    Benzinga
  47. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  48. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  49. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  50. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  51. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  52. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  53. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  54. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  55. Meet 5 Top International Stocks Not Based In China

    IBD
  56. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  57. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  58. Drug giants target Alzheimer's

    IBD
  59. What Is A High Risk Market?

    Benzinga
  60. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  61. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  62. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  63. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  64. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  65. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  66. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  67. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  68. Thursday Morning Earnings Reports

    Benzinga
  69. Earnings Scheduled For July 24, 2014

    Benzinga
  70. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  71. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  72. Benzinga's Top #PreMarket Gainers

    Benzinga
  73. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  74. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  75. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  76. Benzinga's Top Upgrades

    Benzinga
  77. Eli Lilly is on the Right Track

    GuruFocus
  78. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  79. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  80. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  81. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  82. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  83. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  84. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  85. Eli Lilly insulin trial succeeds

    IBD
  86. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  87. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  88. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  89. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  90. Can Pfizer Make Up Its Loss?

    GuruFocus
  91. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  92. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  93. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  94. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  95. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  96. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  97. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  98. Actavis Earns Over-The-Top Q1

    IBD
  99. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  100. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
Trading Center